de Heer, E C <br/><br/>
Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer.  [electronic resource] 

 -  Annals of surgical oncology  Jul 2017 
 - 1811-1820 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1534-4681 
<br/><br/><label>Standard No.: </label>10.1245/s10434-017-5797-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--mortality<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Squamous Cell--mortality<br/>Chemoradiotherapy--mortality<br/>Combined Modality Therapy<br/>Esophageal Neoplasms--mortality<br/>Esophagectomy--mortality<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy--mortality<br/>Neoplasm Invasiveness<br/>Prognosis<br/>Prospective Studies<br/>Retrospective Studies<br/>Survival Rate